Publication | Closed Access
Combined Effects of Chuling (<i>Polyporus umbellatus</i>) Extract and Mitomycin C on Experimental Liver Cancer
32
Citations
0
References
1994
Year
Chemoprevention StrategyMitomycin CImmunologyPathologyExperimental Liver CancerGastrointestinal OncologyCombined EffectsHepatotoxicityAnti-cancer AgentCancer ResearchOncogenic AgentMedicineLiver PhysiologySarcoma 180Cancer TreatmentPharmacologyMalignant DiseaseDrug-induced Liver InjuryTumor MicroenvironmentHepatologyOncologyPolyporus Umbellatus
Chuling (Polyporus umbellatus), one of the commonly used Chinese medical herbs, was combined with mitomycin C and then studied against intrahepatic implantation of sarcoma 180 tumor cells in mice. Oral administration of chuling extract, intraperitoneal injection of mitomycin C and the combination of both increased the life span of tumor-bearing mice 71.6%, 70.1% and 119.9%, respectively. The same treatments were found to be cytotoxic to Sarcoma-180-induced liver tumor cells. The synthetic rates of DNA, RNA and protein were all inhibited measurably by the combined treatment. Histopathological studies showed that lymphocytes infiltrated and surrounded the cancer cells, and there was some fibrosis found in normal cells and cancer cells. These results indicate the potential use of chuling as an anticancer agent.